Effectiveness of the mass antihepatitis B program in preadolescents in Catalonia;Efectividad del programa masivo de vacunación antihepatitis B de los preadolescentes en las escuelas de Cataluña

Medicina Clinica

Volumn 121, Issue SUPPL.1, 2003, Pages 79-82

  Salleras I Sanmartí, Lluís ^a   Bruguera, Miquel ^b   Taberner, Josep Lluís ^a   Domínguez, Àngela ^a   Batalla, Joan ^a   Buti, Maria ^c   Plans, Pere ^a   Navas, Encarna ^d   Costa, Josep ^b   Vidal, Josep ^b   Prats, Ramon ^a   Esteban, Rafael ^c  

^a AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d NONE

Author keywords

Antihepatitis B vaccination; Preadolescents

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE;

ADOLESCENCE; DISEASE PREDISPOSITION; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNITY; PREVALENCE; REVIEW; SEROLOGY; VACCINATION; VIRUS INFECTION;

EID: 8644247738     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Bruguera M, Sánchez Tapias JM. Epidemiología de la hepatitis B en España. Med Clin (Barc) 1990;95:470-5.
2. Esteban JI, Esteban R, Seijo G, Taberner JL, Plans P, Bayas JM, et al. Prevención de la infección por el virus de la hepatitis B en hijos de madres portadoras de HBsAg. An Med Intern (Madrid) 1984;4:112-5.
3. Salleras L, Bruguera JM, Vidal J, et al. Prevalence of hepatitis B markers in the populations of Catalonia (Spain). Rationale for universal vaccination of adolescents. Eur J Epidemiol 1992;8:640-4.
4. Esteban JI, Esteban R. Inmunización activa contra la hepatitis B. Med Clin (Barc) 1982;19:195-7.
5. Bruguera M. ¿Cómo y a quién vacunar contra la hepatitis B en España? Med Clin (Barc) 1984;82:546-8.
6. Salleras L, Bruguera M, Vidal J, Batalla J, Plans P. Estrategias de vacunación antihepatitis B en Cataluña. Gastroenterol Hepatol 1993;16:140-6.
7. Immunization Practices Advisory Committee. Protection against viral hepatitis. MMWR 1985;34:313-24; 329-35.
8. Kane MA, Alter MJ, Hadler SC, Margolis HS. Hepatitis B infection in the United States: recent trends and future strategies for control. Am J Med 1989;87(Suppl 3A):11-3.
9. Immunization Practices Advisory Committee. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. MMWR 1991;40(RR-13):1-35.
10. Bruguera M, Cremades M, Rodício JL, Alcázar JM, Oliver A, Del Río, et al. Immunogenicity of a yeast-derived hepatitis B vaccine in hemodialysis patients. Am J Med 1989;87:30S.
11. Bonanni P. Universal hepatitis B immunization: infant, and infant plus adolescent immunization. Vaccine 1998;16:S17-S22.
12. Departament de Sanitat i Seguretat Social. Document marc per a la elaboració del Pla de Salut de Catalunya. Barcelona: Departament de Sanitat i Seguretat Social, 1991.
13. Salleras L, Plans P, Vidal J, Domínguez A, Navas E, Urbiztondo L. Serological evaluation of the universal hepatitis B vaccination programme of pre-adolescents in Catalonia (Spain). Vacunas 2000;1:3-6.
14. Marsano LS, West DJ, Chan I, Hesley TM, Cox J, Hackworth V, et al. A two-dose hepatitis B vaccine regimen: Proof of priming and memory responses in young adults. Vaccine 1998;16:624-9.
15. Cassidy WM, Watson B, Ioli VA, Williams K, Bird S, West DJ. A randomized trial of alternative two-and three doses hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics 2001;107:626-31.
16. Koff RS. Hepatitis A, hepatitis B, and combination hepatitis vaccines for immunoprophylaxis. An update. Dig Dis Sci 2002;47:1183-94.
17. Domínguez A, Bruguera M, Vidal J, Plans P, Salleras L. Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989-1996. Vaccine 2000;18:2345-50.
18. Lopalco PL, Salleras L, Barbuti S, Germinario C, Bruguera M, Buti M, et al. Hepatitis A and B in children and adolescents -what can we learn from Plugia (Italy) and Catalonia (Spain). Vaccine 2001;19:470-4.
19. Bonanni P, Colombai R, Gasparini R, Lo Nostro A, Tiscione E, Tomei A, et al. Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy. Pediatr Infect Dis 1999;18:677-82.
20. Bonanni P, Crovari P. Success stories in the implementation of universal hepatitis B vaccination: an update on Italy. Vaccine 1998;16:S38-S42.
21. Scheifele D. Universal childhood hepatitis B vaccination: infants vs preadolescents, the Canadian perspective. Pediatr Infect Dis J 1998;17:S35-S7.
22. Zimmerman RK. Assuring up-to-date immunization of children aged 11 to 12 years. Am Fam Physician 1997;55:35-6.
23. Cassidy W. School-based adolescent hepatitis B immunization programs in the United States: strategies and successes. Ped Infect Dis J 1998;17:S43-S6.
24. Mast EE, Mahoney FJ, Alter MJ, Margolis HS. Progress towards elimination of hepatitis B virus transmission in the United States. Vaccine 1998;16:S48-S51.
25. Schaffer SJ, Humiston SG, Shone LP, Averhoff FM, Szilagyi PG. Adolescent immunization practices. A national survey of US phyisicians. Arch Pediatr Adolesc Med 2001;155:566-71.
26. Goldstein ST, Alter MJ, Williams IT, Moyer LA, Judson FN, Mottram K, et al. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implication for vaccination programs. J Infect Dis 2002;185:713-9.
27. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001;135:796-800.
28. Kao JH, Hsu HM, Shau WY, Chang MH, Chen DS. Universal hepatitis B vaccination and the decreased mortality from fulminant hepatitis in infants in Taiwan. J Pediatr 2001;139:349-52.
29. Tsebe KV, Burnett RJ, Hlungwani NP, Sibara MM, Venter PA, Mphahlele MJ. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds. Vaccine 2001;19:3919-26.
30. Hino K, Katoh Y, Vardas E, Sim J, Okita K, Carman WF. The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. Vaccine 2001;19:3912-8.
31. Whittle H, Jaffar S, Wansborough M, Mendy M, Dumpis U, Collinson A, et al. Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children. BMJ 2002;325:569.
32. Wilson N, Ruff TA, Rana BJ, Leydon J, Locarnini S. The effectiveness of the infant hepatitis B immunization program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine 2000;18:3059-66.
33. Goldstein T, Fiore AE. Toward the global elimination of hepatitis B virus transmission. J Pediatr 2001;139:343-5.
34. Kao J, Chen D. Global control of hepatitis B virus infection. Lancet Infect Dis 2002;2:395-403.